CDT Equity Inc. Cash Flow Conversion Efficiency
CDT Equity Inc. cash flow conversion efficiency. Based on the latest financial reports, CDT Equity Inc. (CDT) has a cash flow conversion efficiency ratio of 0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($42.74 Million) by net assets ($1.38 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CDT Equity Inc. (2021–2025)
Cash flow conversion efficiency of CDT Equity Inc. from 2021 to 2025. This chart illustrates how CDT Equity Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View CDT Equity Inc. stock price for real-time trading data and today's change.
CDT Equity Inc. Cash Flow Conversion Ratio Explained
CDT Equity Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CDT Equity Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CDT Equity Inc. ranked by their cash flow conversion efficiency. Also see CDT Equity Inc. (CDT) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nvni Group Limited
NASDAQ:NVNIF
|
N/A |
|
Network Media Group Inc
V:NTE
|
0.082x |
|
H&G High Conviction Ltd
AU:HCF
|
-0.275x |
|
LEGIBLE INC.
F:D0T
|
N/A |
|
in Style Group PLC
LSE:ITS
|
-0.054x |
|
Shoe Zone PLC
LSE:SHOE
|
0.326x |
|
IMMOTION GRP LS-0004010
F:6XK
|
N/A |
|
Star Energy Group Plc
LSE:STAR
|
0.093x |
Annual Cash Flow Conversion Efficiency for CDT Equity Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of CDT Equity Inc. from 2021 to 2025. Review CDT Equity Inc. free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.26 Billion | $-15.55 Million | -0.012x | -100.86% |
| 2024-12-31 | $-6.79 Million | $-9.68 Million | 1.425x | -91.57% |
| 2023-12-31 | $-457.00K | $-7.72 Million | 16.904x | +7426.11% |
| 2022-12-31 | $-10.09 Million | $-2.27 Million | 0.225x | +100.22% |
| 2021-12-31 | $20.62K | $-2.15 Million | -104.321x | -- |
About CDT Equity Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the tre… Read more